Ratio Examination: Boston Scientific Corp. (BSX)’s Price-to-Cash and Price-to-Free Cash Flow

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Boston Scientific Corp. (NYSE: BSX) closed at $74.26 down -4.50% from its previous closing price of $77.76. In other words, the price has decreased by -$4.50 from its previous closing price. On the day, 10.94 million shares were traded. BSX stock price reached its highest trading level at $78.745 during the session, while it also had its lowest trading level at $74.13.

Ratios:

For a deeper understanding of Boston Scientific Corp.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 64.30. For the most recent quarter (mrq), Quick Ratio is recorded 1.14 and its Current Ratio is at 1.66. In the meantime, Its Debt-to-Equity ratio is 0.55 whereas as Long-Term Debt/Eq ratio is at 0.50.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on May 30, 2024, initiated with a Buy rating and assigned the stock a target price of $90.

On February 01, 2024, Mizuho Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $65 to $80.

On July 19, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $59.Robert W. Baird initiated its Outperform rating on July 19, 2023, with a $59 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 01 ’24 when Carruthers Wendy sold 6,983 shares for $77.30 per share. The transaction valued at 539,786 led to the insider holds 42,908 shares of the business.

Carruthers Wendy sold 6,983 shares of BSX for $526,029 on Jun 03 ’24. The EVP, Human Resources now owns 45,628 shares after completing the transaction at $75.33 per share. On May 29 ’24, another insider, Mirviss Jeffrey B., who serves as the EVP&Pres, Periph Intervent of the company, sold 63,802 shares for $75.10 each. As a result, the insider received 4,791,447 and left with 28,022 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BSX now has a Market Capitalization of 109175570432 and an Enterprise Value of 118089555968. As of this moment, Boston’s Price-to-Earnings (P/E) ratio for their current fiscal year is 60.00, and their Forward P/E ratio for the next fiscal year is 27.37. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.84. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.17 while its Price-to-Book (P/B) ratio in mrq is 5.48. Its current Enterprise Value per Revenue stands at 7.754 whereas that against EBITDA is 29.851.

Stock Price History:

The Beta on a monthly basis for BSX is 0.78, which has changed by 0.43664157 over the last 52 weeks, in comparison to a change of 0.17829525 over the same period for the S&P500. Over the past 52 weeks, BSX has reached a high of $79.43, while it has fallen to a 52-week low of $48.35. The 50-Day Moving Average of the stock is -2.72%, while the 200-Day Moving Average is calculated to be 14.25%.

Shares Statistics:

For the past three months, BSX has traded an average of 5.89M shares per day and 7755960 over the past ten days. A total of 1.47B shares are outstanding, with a floating share count of 1.46B. Insiders hold about 0.45% of the company’s shares, while institutions hold 93.02% stake in the company. Shares short for BSX as of 1721001600 were 11525968 with a Short Ratio of 1.96, compared to 1718323200 on 11539004. Therefore, it implies a Short% of Shares Outstanding of 11525968 and a Short% of Float of 0.7900001.

Most Popular